You are using an older browser version. Please use a supported version for the best MSN experience.

SPDR® S&P Biotech ETF

NYSE ARCA: XBI
61.81
+0.67
+1.10%
12/2/2016 7:59 PM EST
5 Years
  • Open

    61.11

  • Previous Close

    61.14

  • Vol (3-Month Avg.)

    6.77M

  • Day's Range

    60.60-62.67

  • 52 week range

    44.16-72.23

  • Net Assets

    2.99B

  • Yield

    0.45%

  • Category

    Health

  • Morningstar Risk

    High

Profile

Name of Issuer

SPDR State Street Global Advisors

Expenses

0.35%

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Inception

1/31/2006

AdChoices
image beaconimage beaconimage beacon